{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T20:53:52Z","timestamp":1788468832339,"version":"build-2803163510"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,2]],"date-time":"2024-03-02T00:00:00Z","timestamp":1709337600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006484","name":"CSL Vifor","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006484","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010665","name":"Horizon 2020 Marie Sk\u0142odowska-Curie Actions","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.jconrel.2024.02.044","type":"journal-article","created":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T20:27:28Z","timestamp":1710361648000},"page":"566-579","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Iron-carbohydrate complexes treating iron anaemia: Understanding the nano-structure and interactions with proteins through orthogonal characterisation"],"prefix":"10.1016","volume":"368","author":[{"given":"Leonard","family":"Krupnik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Avaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Liebi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neda Iranpour","family":"Anaraki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Kohlbrecher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alla","family":"Sologubenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Handschin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrzej J.","family":"Rzepiela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Appel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiberiu","family":"Totu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clement E.","family":"Blanchet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy E. Barton","family":"Alston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinaldo","family":"Digigow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Philipp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beat","family":"Fl\u00fchmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno F.B.","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia","family":"Neels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Wick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2024.02.044_bb0005","unstructured":"De Benoist, B.; Cogswell, M.; Egli, I.; McLean, E. Worldwide Prevalence of Anaemia 1993-2005; WHO Global Database of Anaemia. 2008."},{"issue":"3","key":"10.1016\/j.jconrel.2024.02.044_bb0010","first-page":"287","article-title":"Intravenous iron and safety: is the end of the debate on the horizon?","volume":"12","author":"Mu\u00f1oz","year":"2014","journal-title":"Blood Transfus."},{"issue":"5","key":"10.1016\/j.jconrel.2024.02.044_bb0015","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1007\/s12325-020-01323-z","article-title":"Iron sucrose: a wealth of experience in treating iron deficiency","volume":"37","author":"Macdougall","year":"2020","journal-title":"Adv. Ther."},{"issue":"2","key":"10.1016\/j.jconrel.2024.02.044_bb0020","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/joim.13004","article-title":"Iron deficiency anaemia revisited","volume":"287","author":"Cappellini","year":"2020","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.jconrel.2024.02.044_bb0025","doi-asserted-by":"crossref","first-page":"4357","DOI":"10.2147\/IJN.S46900","article-title":"Nanopharmaceuticals (part 1): products on the market","volume":"9","author":"Weissig","year":"2014","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2024.02.044_bb0030","doi-asserted-by":"crossref","first-page":"102178","DOI":"10.1016\/j.nano.2020.102178","article-title":"Factors influencing safety and efficacy of intravenous iron-carbohydrate nanomedicines: from production to clinical practice","volume":"26","author":"Nikravesh","year":"2020","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"10.1016\/j.jconrel.2024.02.044_bb0035","first-page":"13","article-title":"Safety and efficacy of intravenous administration of iron preparations","volume":"74","author":"Grzywacz","year":"2017","journal-title":"Acta Pol. Pharm."},{"issue":"1","key":"10.1016\/j.jconrel.2024.02.044_bb0040","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1182\/asheducation-2010.1.338","article-title":"Clinical use of intravenous iron: administration, efficacy, and safety","volume":"2010","author":"Auerbach","year":"2010","journal-title":"Hematology"},{"issue":"1","key":"10.1016\/j.jconrel.2024.02.044_bb0045","first-page":"66","article-title":"Comparison of oxidative stress and inflammation induced by different intravenous Iron sucrose similar preparations in a rat model","volume":"11","author":"Eduardo Toblli","year":"2012","journal-title":"Inflamm. Allergy \u2013 Drug Targets Former. Curr. Drug Targets \u2013 Inflamm. Allergy"},{"issue":"10","key":"10.1016\/j.jconrel.2024.02.044_bb0050","doi-asserted-by":"crossref","first-page":"3673","DOI":"10.1007\/s00604-017-2388-8","article-title":"The fate of Iron nanoparticles used for treatment of iron deficiency in blood using mass-spectrometry based strategies","volume":"184","author":"Garc\u00eda-Fern\u00e1ndez","year":"2017","journal-title":"Microchim. Acta"},{"issue":"11","key":"10.1016\/j.jconrel.2024.02.044_bb0055","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/j.jinorgbio.2004.06.010","article-title":"Structure of carbohydrate-bound polynuclear iron oxyhydroxide nanoparticles in parenteral formulations","volume":"98","author":"Kudasheva","year":"2004","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.jconrel.2024.02.044_bb0060","series-title":"Compendium of Chemical Terminology","volume":"1669","author":"McNaught","year":"1997"},{"key":"10.1016\/j.jconrel.2024.02.044_bb0065","series-title":"Non-Biological Complex Drugs: The Science and the Regulatory Landscape","first-page":"149","article-title":"Iron carbohydrate complexes: characteristics and regulatory challenges","author":"M\u00fchlebach","year":"2015"},{"issue":"2","key":"10.1016\/j.jconrel.2024.02.044_bb0070","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.yrtph.2012.08.009","article-title":"Nanoparticle Iron medicinal products \u2013 requirements for approval of intended copies of non-biological complex drugs (NBCD) and the importance of clinical comparative studies","volume":"64","author":"Borchard","year":"2012","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.jconrel.2024.02.044_bb0075","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ejpb.2022.03.006","article-title":"Tissue biodistribution of intravenous iron-carbohydrate nanomedicines differs between preparations with varying physicochemical characteristics in an anemic rat model","volume":"174","author":"Funk","year":"2022","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"4","key":"10.1016\/j.jconrel.2024.02.044_bb0080","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.3390\/ijms23042140","article-title":"Criticality of surface characteristics of intravenous iron\u2013carbohydrate nanoparticle complexes: implications for pharmacokinetics and pharmacodynamics","volume":"23","author":"Funk","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.jconrel.2024.02.044_bb0085","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1182\/blood.V1.2.129.129","article-title":"Observations on the effect of massive doses of iron given intravenously to patients with hypochromic anemia","volume":"1","author":"Goetsch","year":"1946","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.jconrel.2024.02.044_bb0090","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3390\/pharmaceutics3010012","article-title":"The pharmacokinetics and pharmacodynamics of iron preparations","volume":"3","author":"Geisser","year":"2011","journal-title":"Pharmaceutics"},{"issue":"6","key":"10.1016\/j.jconrel.2024.02.044_bb0095","first-page":"345","article-title":"The new generation of intravenous iron: chemistry, pharmacology, and toxicology of ferric carboxymaltose","volume":"60","author":"Funk","year":"2010","journal-title":"Arzneimittelforschung"},{"issue":"Suppl. 2","key":"10.1016\/j.jconrel.2024.02.044_bb0100","first-page":"S93","article-title":"Structure, chemistry, and pharmacokinetics of intravenous iron agents","volume":"15","author":"Danielson","year":"2004","journal-title":"J. Am. Soc. Nephrol."},{"issue":"1","key":"10.1016\/j.jconrel.2024.02.044_bb0105","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.drudis.2019.09.020","article-title":"Iron oxide nanoparticles for therapeutic applications","volume":"25","author":"Alphand\u00e9ry","year":"2020","journal-title":"Drug Discov. Today"},{"issue":"1","key":"10.1016\/j.jconrel.2024.02.044_bb0110","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3390\/nano8010025","article-title":"Comparative evaluation of U.S. brand and generic intravenous sodium ferric gluconate complex in sucrose injection: physicochemical characterization","volume":"8","author":"Sun","year":"2018","journal-title":"Nanomaterials"},{"issue":"10","key":"10.1016\/j.jconrel.2024.02.044_bb0115","doi-asserted-by":"crossref","first-page":"3262","DOI":"10.1093\/ndt\/gfr024","article-title":"Do two intravenous iron sucrose preparations have the same efficacy?","volume":"26","author":"Rottembourg","year":"2011","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.jconrel.2024.02.044_bb0120","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/j.freeradbiomed.2013.09.001","article-title":"The complex interplay of iron metabolism, reactive oxygen species, and reactive nitrogen species: insights into the potential of various iron therapies to induce oxidative and nitrosative stress","volume":"65","author":"Koskenkorva-Frank","year":"2013","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.jconrel.2024.02.044_bb0125","doi-asserted-by":"crossref","first-page":"115404","DOI":"10.1016\/j.biopha.2023.115404","article-title":"Uncovering the dynamics of cellular responses induced by iron-carbohydrate complexes in human macrophages using quantitative proteomics and phosphoproteomics","volume":"166","author":"Bossart","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"10","key":"10.1016\/j.jconrel.2024.02.044_bb0130","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.1182\/blood.V99.10.3505","article-title":"Regulation of ferritin genes and protein","volume":"99","author":"Torti","year":"2002","journal-title":"Blood"},{"issue":"36","key":"10.1016\/j.jconrel.2024.02.044_bb0135","doi-asserted-by":"crossref","first-page":"1907650","DOI":"10.1002\/smll.201907650","article-title":"Understanding nanomaterial biotransformation: an unmet challenge to achieving predictive nanotoxicology","volume":"16","author":"Milosevic","year":"2020","journal-title":"Small"},{"issue":"17","key":"10.1016\/j.jconrel.2024.02.044_bb0140","doi-asserted-by":"crossref","first-page":"6287","DOI":"10.1039\/C4CS00487F","article-title":"Nanoparticle colloidal stability in cell culture media and impact on cellular interactions","volume":"44","author":"Moore","year":"2015","journal-title":"Chem. Soc. Rev."},{"issue":"7","key":"10.1016\/j.jconrel.2024.02.044_bb0145","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1073\/pnas.0608582104","article-title":"Understanding the nanoparticle\u2013protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles","volume":"104","author":"Cedervall","year":"2007","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"38","key":"10.1016\/j.jconrel.2024.02.044_bb0150","doi-asserted-by":"crossref","first-page":"14265","DOI":"10.1073\/pnas.0805135105","article-title":"Nanoparticle size and surface properties determine the protein Corona with possible implications for biological impacts","volume":"105","author":"Lundqvist","year":"2008","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"9","key":"10.1016\/j.jconrel.2024.02.044_bb0155","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/nnano.2009.195","article-title":"A quantitative fluorescence study of protein monolayer formation on colloidal nanoparticles","volume":"4","author":"R\u00f6cker","year":"2009","journal-title":"Nat. Nanotechnol."},{"issue":"suppl_1","key":"10.1016\/j.jconrel.2024.02.044_bb0160","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1098\/rsif.2009.0272.focus","article-title":"Quantitative analysis of the protein Corona on FePt nanoparticles formed by transferrin binding","volume":"7","author":"Jiang","year":"2010","journal-title":"J. R. Soc. Interface"},{"issue":"9","key":"10.1016\/j.jconrel.2024.02.044_bb0165","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1039\/C2CP42641B","article-title":"Size control of laser-fabricated surfactant-free gold nanoparticles with highly diluted electrolytes and their subsequent bioconjugation","volume":"15","author":"Rehbock","year":"2013","journal-title":"Phys. Chem. Chem. Phys."},{"issue":"3","key":"10.1016\/j.jconrel.2024.02.044_bb0170","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1039\/B914875B","article-title":"The influence of proteins on the dispersability and cell-biological activity of silver nanoparticles","volume":"20","author":"Kittler","year":"2009","journal-title":"J. Mater. Chem."},{"issue":"25","key":"10.1016\/j.jconrel.2024.02.044_bb0175","doi-asserted-by":"crossref","first-page":"9673","DOI":"10.1021\/la301104a","article-title":"Impact of the nanoparticle\u2013protein Corona on colloidal stability and protein structure","volume":"28","author":"Gebauer","year":"2012","journal-title":"Langmuir"},{"issue":"6","key":"10.1016\/j.jconrel.2024.02.044_bb0180","doi-asserted-by":"crossref","first-page":"5515","DOI":"10.1021\/nn4061012","article-title":"Secreted biomolecules alter the biological identity and cellular interactions of nanoparticles","volume":"8","author":"Albanese","year":"2014","journal-title":"ACS Nano"},{"issue":"4","key":"10.1016\/j.jconrel.2024.02.044_bb0185","doi-asserted-by":"crossref","first-page":"3253","DOI":"10.1021\/nn3059295","article-title":"Polymer-coated nanoparticles interacting with proteins and cells: focusing on the sign of the net charge","volume":"7","author":"H\u00fchn","year":"2013","journal-title":"ACS Nano"},{"issue":"17","key":"10.1016\/j.jconrel.2024.02.044_bb0190","doi-asserted-by":"crossref","first-page":"6094","DOI":"10.1039\/C5CS00217F","article-title":"The nanoparticle biomolecule Corona: lessons learned \u2013 challenge accepted?","volume":"44","author":"Docter","year":"2015","journal-title":"Chem. Soc. Rev."},{"issue":"3","key":"10.1016\/j.jconrel.2024.02.044_bb0195","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.bbrc.2015.06.178","article-title":"Keeping it real: The importance of material characterization in nanotoxicology","volume":"468","author":"Fadeel","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jconrel.2024.02.044_bb0200","author":"Research, C. for D. E"},{"key":"10.1016\/j.jconrel.2024.02.044_bb0205","unstructured":"EMA. Reflection Paper on the Data Requirements for Intravenous Iron-Based Nano-Colloidal Products Developed with Reference to an Innovator Medicinal Product. http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2015\/03\/WC500184922.pdf (accessed 2024-02-10)."},{"key":"10.1016\/j.jconrel.2024.02.044_bb0210","doi-asserted-by":"crossref","first-page":"106521","DOI":"10.1016\/j.ejps.2023.106521","article-title":"Critical nanomaterial attributes of iron-carbohydrate nanoparticles: leveraging orthogonal methods to resolve the 3-dimensional structure","volume":"188","author":"Krupnik","year":"2023","journal-title":"Eur. J. Pharm. Sci."},{"issue":"7","key":"10.1016\/j.jconrel.2024.02.044_bb0215","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1021\/acsabm.9b00386","article-title":"Insights into preformed human serum albumin Corona on iron oxide nanoparticles: structure, effect of particle size, impact on MRI efficiency, and metabolization","volume":"2","author":"Moya","year":"2019","journal-title":"ACS Appl. Bio Mater."},{"issue":"8","key":"10.1016\/j.jconrel.2024.02.044_bb0220","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.3109\/10717544.2015.1048488","article-title":"Albumin Corona on nanoparticles - a strategic approach in drug delivery","volume":"23","author":"Mariam","year":"2016","journal-title":"Drug Deliv."},{"issue":"3","key":"10.1016\/j.jconrel.2024.02.044_bb0225","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.mam.2011.12.002","article-title":"Human serum albumin: from bench to bedside","volume":"33","author":"Fanali","year":"2012","journal-title":"Mol. Aspects Med."},{"issue":"8","key":"10.1016\/j.jconrel.2024.02.044_bb0230","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1111\/j.1538-7836.2005.01365.x","article-title":"Fibrinogen and fibrin structure and functions","volume":"3","author":"Mosesson","year":"2005","journal-title":"J. Thromb. Haemost."},{"issue":"7","key":"10.1016\/j.jconrel.2024.02.044_bb0235","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S1357-2725(99)00032-1","article-title":"Fibrinogen","volume":"31","author":"Herrick","year":"1999","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"1","key":"10.1016\/j.jconrel.2024.02.044_bb0240","doi-asserted-by":"crossref","first-page":"s1455","DOI":"10.1007\/s003390201561","article-title":"The new \u2018BerSANS-PC\u2019 software for reduction and treatment of small angle neutron scattering data","volume":"74","author":"Keiderling","year":"2002","journal-title":"Appl. Phys. A Mater. Sci. Process."},{"issue":"3","key":"10.1016\/j.jconrel.2024.02.044_bb0245","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.ejpb.2011.03.016","article-title":"A comparative study of the physicochemical properties of iron isomaltoside 1000 (Monofer\u00ae), a new intravenous Iron preparation and its clinical implications","volume":"78","author":"Jahn","year":"2011","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"1\u20132","key":"10.1016\/j.jconrel.2024.02.044_bb0250","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ijpharm.2016.03.029","article-title":"Core size determination and structural characterization of intravenous iron complexes by cryogenic transmission electron microscopy","volume":"505","author":"Wu","year":"2016","journal-title":"Int. J. Pharm."},{"issue":"4","key":"10.1016\/j.jconrel.2024.02.044_bb0255","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s10534-015-9845-9","article-title":"Physico-chemical properties of the new generation IV iron preparations ferumoxytol, iron isomaltoside 1000 and ferric carboxymaltose","volume":"28","author":"Neiser","year":"2015","journal-title":"BioMetals"},{"key":"10.1016\/j.jconrel.2024.02.044_bb0260","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jpba.2013.08.005","article-title":"Structural characterization of iron oxide\/hydroxide nanoparticles in nine different parenteral drugs for the treatment of iron deficiency anaemia by electron diffraction (ED) and X-ray powder diffraction (XRPD)","volume":"86","author":"F\u00fctterer","year":"2013","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"1","key":"10.1016\/j.jconrel.2024.02.044_bb0265","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/nyas.13517","article-title":"Iron sucrose: assessing the similarity between the originator drug and its intended copies","volume":"1407","author":"Francesco","year":"2017","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"37","key":"10.1016\/j.jconrel.2024.02.044_bb0270","doi-asserted-by":"crossref","first-page":"12180","DOI":"10.1021\/acs.langmuir.9b02094","article-title":"Structural properties and magnetic ordering in 2D polymer nanocomposites: existence of long magnetic dipolar chains in zero field","volume":"35","author":"Appel","year":"2019","journal-title":"Langmuir"},{"issue":"5","key":"10.1016\/j.jconrel.2024.02.044_bb0275","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/j.msec.2006.09.002","article-title":"SAXS study of chain-like structures formed by magnetic nanoparticles","volume":"27","author":"Bonini","year":"2007","journal-title":"Mater. Sci. Eng. C"},{"issue":"12","key":"10.1016\/j.jconrel.2024.02.044_bb0280","doi-asserted-by":"crossref","first-page":"3548","DOI":"10.1021\/la404712r","article-title":"Resolving early stages of homogeneous iron(III) oxyhydroxide formation from Iron(III) nitrate solutions at pH 3 using time-resolved SAXS","volume":"30","author":"Rose","year":"2014","journal-title":"Langmuir"},{"issue":"3","key":"10.1016\/j.jconrel.2024.02.044_bb0285","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.ejpb.2013.11.003","article-title":"13C NMR spectroscopy as a tool for the in situ characterisation of Iron-supplementing preparations","volume":"86","author":"K\u00e4stele","year":"2014","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"5","key":"10.1016\/j.jconrel.2024.02.044_bb0290","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1107\/S0365110X52001908","article-title":"The crystal structure of sucrose","volume":"5","author":"Beevers","year":"1952","journal-title":"Acta Crystallogr."},{"issue":"11","key":"10.1016\/j.jconrel.2024.02.044_bb0295","doi-asserted-by":"crossref","first-page":"4985","DOI":"10.1021\/nl202940k","article-title":"Soft interactions at nanoparticles alter protein function and conformation in a size dependent manner","volume":"11","author":"Wang","year":"2011","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2024.02.044_bb0300","doi-asserted-by":"crossref","unstructured":"Iranpour Anaraki, N.; Liebi, M.; Ong, Q.; Blanchet, C.; Maurya, A. K.; Stellacci, F.; Salentinig, S.; Wick, P.; Neels, A. In-Situ investigations on gold nanoparticles stabilization mechanisms in biological environments containing HSA. Adv. Funct. Mater. n\/a (n\/a), 2110253. https:\/\/doi.org\/10.1002\/adfm.202110253.","DOI":"10.1002\/adfm.202110253"},{"issue":"3","key":"10.1016\/j.jconrel.2024.02.044_bb0305","first-page":"423","article-title":"Size of a human serum albumin molecule in solution","volume":"46","author":"Kiselev","year":"2001","journal-title":"Biofizika"},{"issue":"3","key":"10.1016\/j.jconrel.2024.02.044_bb0310","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/med.10039","article-title":"In silico prediction of drug-binding strengths to human serum albumin","volume":"23","author":"Colmenarejo","year":"2003","journal-title":"Med. Res. Rev."},{"issue":"1","key":"10.1016\/j.jconrel.2024.02.044_bb0315","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1006\/jcis.1999.6159","article-title":"Conformational changes of fibrinogen adsorption onto hydroxyapatite and titanium oxide nanoparticles","volume":"214","author":"Yongli","year":"1999","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.jconrel.2024.02.044_bb0320","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.bios.2015.05.070","article-title":"A quantitative binding study of fibrinogen and human serum albumin to metal oxide nanoparticles by surface plasmon resonance","volume":"74","author":"Canoa","year":"2015","journal-title":"Biosens. Bioelectron."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365924001408?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365924001408?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T16:35:19Z","timestamp":1738082119000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365924001408"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":64,"alternative-id":["S0168365924001408"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2024.02.044","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Iron-carbohydrate complexes treating iron anaemia: Understanding the nano-structure and interactions with proteins through orthogonal characterisation","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2024.02.044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}